Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis.


Journal

Cardiovascular diabetology
ISSN: 1475-2840
Titre abrégé: Cardiovasc Diabetol
Pays: England
ID NLM: 101147637

Informations de publication

Date de publication:
22 01 2021
Historique:
received: 04 12 2020
accepted: 09 01 2021
entrez: 23 1 2021
pubmed: 24 1 2021
medline: 6 10 2021
Statut: epublish

Résumé

There remain uncertainties regarding diabetes mellitus and the incidence of atrial fibrillation (AF), in relation to type of diabetes, and the interactions with sex and age. We investigated whether diabetes confers higher relative rates of AF in women compared to men, and whether these sex-differences depend on type of diabetes and age. All patients aged ≥ 18 seen in French hospitals in 2013 with at least 5 years of follow-up without a history of AF were identified and categorized by their diabetes status. We calculated overall and age-dependent incidence rates, hazard ratios, and women-to-men ratios for incidence of AF in patients with type 1 and type 2 diabetes (compared to no diabetes). In 2,921,407 patients with no history of AF (55% women), 45,389 had prevalent type 1 diabetes and 345,499 had prevalent type 2 diabetes. The incidence rates (IRs) of AF were higher in type 1 or type 2 diabetic patients than in non-diabetics, and increased with advancing age. Among individuals with diabetes, the absolute rate of AF was higher in men than in women. When comparing individuals with and without diabetes, women had a higher adjusted hazard ratio (HR) of AF than men: adjusted HR 1.32 (95% confidence interval 1.27-1.37) in women vs. 1.12(1.08-1.16) in men for type 1 diabetes, adjusted HR 1.17(1.16-1.19) in women vs. 1.10(1.09-1.12) in men for type 2 diabetes. Although men have higher absolute rates for incidence of AF, the relative rates of incident AF associated with diabetes are higher in women than in men for both type 1 and type 2 diabetes.

Sections du résumé

BACKGROUND
There remain uncertainties regarding diabetes mellitus and the incidence of atrial fibrillation (AF), in relation to type of diabetes, and the interactions with sex and age. We investigated whether diabetes confers higher relative rates of AF in women compared to men, and whether these sex-differences depend on type of diabetes and age.
METHODS
All patients aged ≥ 18 seen in French hospitals in 2013 with at least 5 years of follow-up without a history of AF were identified and categorized by their diabetes status. We calculated overall and age-dependent incidence rates, hazard ratios, and women-to-men ratios for incidence of AF in patients with type 1 and type 2 diabetes (compared to no diabetes).
RESULTS
In 2,921,407 patients with no history of AF (55% women), 45,389 had prevalent type 1 diabetes and 345,499 had prevalent type 2 diabetes. The incidence rates (IRs) of AF were higher in type 1 or type 2 diabetic patients than in non-diabetics, and increased with advancing age. Among individuals with diabetes, the absolute rate of AF was higher in men than in women. When comparing individuals with and without diabetes, women had a higher adjusted hazard ratio (HR) of AF than men: adjusted HR 1.32 (95% confidence interval 1.27-1.37) in women vs. 1.12(1.08-1.16) in men for type 1 diabetes, adjusted HR 1.17(1.16-1.19) in women vs. 1.10(1.09-1.12) in men for type 2 diabetes.
CONCLUSION
Although men have higher absolute rates for incidence of AF, the relative rates of incident AF associated with diabetes are higher in women than in men for both type 1 and type 2 diabetes.

Identifiants

pubmed: 33482830
doi: 10.1186/s12933-021-01216-7
pii: 10.1186/s12933-021-01216-7
pmc: PMC7821402
doi:

Types de publication

Comparative Study Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

24

Références

Proc Natl Acad Sci U S A. 2020 Apr 7;117(14):7990-8000
pubmed: 32198206
Eur Heart J. 2020 Apr 1;41(13):1346-1353
pubmed: 31860067
Diabetes Care. 2008 Jul;31(7):1389-91
pubmed: 18375411
Am J Cardiol. 2011 Jul 1;108(1):56-62
pubmed: 21529739
Endocr Rev. 2016 Jun;37(3):278-316
pubmed: 27159875
Diabetes Obes Metab. 2020 Feb;22(2):263-266
pubmed: 31486272
Stroke. 2015 Sep;46(9):2432-7
pubmed: 26251249
BMC Cardiovasc Disord. 2019 Nov 28;19(1):270
pubmed: 31779588
J Clin Epidemiol. 2011 Sep;64(9):1014-22
pubmed: 21330103
Circulation. 2000 May 2;101(17):2040-6
pubmed: 10790344
Cardiovasc Diabetol. 2013 Apr 09;12:61
pubmed: 23570342
Cardiovasc Diabetol. 2019 Sep 24;18(1):121
pubmed: 31551089
Int J Cardiol. 2016 Nov 15;223:953-957
pubmed: 27589043
Int J Cardiol. 2005 Dec 7;105(3):315-8
pubmed: 16274775
Diabetes. 2019 Mar;68(3):631-636
pubmed: 30409780
Thromb Haemost. 2017 May 3;117(5):837-850
pubmed: 28229164
Circulation. 2020 Apr 14;141(15):1227-1234
pubmed: 31983236
Cardiovasc Diabetol. 2019 Nov 16;18(1):157
pubmed: 31733656
J Cardiovasc Electrophysiol. 2020 Dec;31(12):3176-3186
pubmed: 32966681
Circulation. 2018 Dec 11;138(24):2774-2786
pubmed: 29950404
Int J Cardiol. 2018 Jul 1;262:66-70
pubmed: 29605469
Eur Heart J. 2009 May;30(9):1128-35
pubmed: 19282274
Circulation. 2019 Jun 11;139(24):2742-2753
pubmed: 30986362
Diabetes Care. 2013 Sep;36(9):2582-90
pubmed: 23564923
Eur Heart J. 2020 Aug 29;:
pubmed: 32860505
Cardiovasc Diabetol. 2019 Oct 1;18(1):128
pubmed: 31575379
Lancet Diabetes Endocrinol. 2017 Oct;5(10):799-807
pubmed: 28838683
Heart. 2012 Jan;98(2):133-8
pubmed: 21930722
Int J Cardiol. 2011 Dec 1;153(2):233-4
pubmed: 21985750
Circulation. 2020 Jan 28;141(4):260-268
pubmed: 31736332
Cardiovasc Diabetol. 2020 Jan 18;19(1):9
pubmed: 31954408
J Am Coll Cardiol. 2012 Oct 9;60(15):1421-8
pubmed: 22981550
Diabetes Care. 2005 Mar;28(3):514-20
pubmed: 15735180
Cardiovasc Diabetol. 2020 Jun 13;19(1):78
pubmed: 32534567
Diabetes Ther. 2020 Feb;11(2):535-548
pubmed: 31953694
Eur J Prev Cardiol. 2016 Apr;23(6):621-7
pubmed: 26254188
Lancet. 2010 Jun 26;375(9733):2215-22
pubmed: 20609967
Eur J Intern Med. 2017 Jul;42:67-73
pubmed: 28506809

Auteurs

Arnaud Bisson (A)

Service de Cardiologie, Centre Hospitalier Universitaire Et Faculté de Médecine, Université de Tours, Hôpital Trousseau, 37044, Tours, France.

Alexandre Bodin (A)

Service de Cardiologie, Centre Hospitalier Universitaire Et Faculté de Médecine, Université de Tours, Hôpital Trousseau, 37044, Tours, France.

Grégoire Fauchier (G)

Service de Médecine Interne, Unité D'Endocrinologie Diabétologie Et Nutrition, Centre Hospitalier Universitaire Et Faculté de Médecine, Université de Tours, Tours, France.

Julien Herbert (J)

Service de Cardiologie, Centre Hospitalier Universitaire Et Faculté de Médecine, Université de Tours, Hôpital Trousseau, 37044, Tours, France.
Service D'information Médicale, D'épidémiologie Et D'économie de La Santé, Centre Hospitalier Universitaire Et Faculté de Médecine, Université de Tours, EA7505, Tours, France.

Denis Angoulvant (D)

Service de Cardiologie, Centre Hospitalier Universitaire Et Faculté de Médecine, Université de Tours, Hôpital Trousseau, 37044, Tours, France.
EA4245 T2i, Université de Tours, Tours, France.

Pierre Henri Ducluzeau (PH)

Service de Médecine Interne, Unité D'Endocrinologie Diabétologie Et Nutrition, Centre Hospitalier Universitaire Et Faculté de Médecine, Université de Tours, Tours, France.
INRAE (Institut National de Recherche Pour L'Agriculture, l'Alimentation Et L'Environnement), Unité Mixte de Recherche Physiologie de La Reproduction Et Des Comportements, 37380, Nouzilly, France.

Gregory Y H Lip (GYH)

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, UK.
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Laurent Fauchier (L)

Service de Cardiologie, Centre Hospitalier Universitaire Et Faculté de Médecine, Université de Tours, Hôpital Trousseau, 37044, Tours, France. lfau@univ-tours.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH